Achieve Life Sciences, Inc. Interest Receivable, Current
Achieve Life Sciences, Inc. (ACHV) had Interest Receivable, Current of $32.00 thousand as of 2016-12-31, per its 10-Q filed 2017-07-31.
Discontinued › Notes
us-gaap:InterestReceivableCurrent · last filed 2017-07-31
- 2016-12-31: Interest Receivable, Current $32.00K.
- 2016-09-30: Interest Receivable, Current $36.00K.
- 2016-06-30: Interest Receivable, Current $47.00K.
- 2016-03-31: Interest Receivable, Current $53.00K.
| Period end | Interest Receivable, Current |
|---|---|
| 2016-12-31 | $32.00K 10-Q · filed 2017-07-31 |
| 2016-09-30 | $36.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $47.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $53.00K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $111.00K 10-K · filed 2017-02-23 |
| 2015-09-30 | $48.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $76.00K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $71.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $113.00K 10-K · filed 2016-03-09 |
| 2014-09-30 | $19.00K 10-Q · filed 2014-10-30 |
| 2014-03-31 | $166.00K 10-Q · filed 2014-04-30 |
| 2013-12-31 | $218.00K 10-K · filed 2015-03-26 |
| 2013-09-30 | $295.00K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $300.00K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $321.00K 10-Q · filed 2013-05-02 |
| 2012-12-31 | $327.00K 10-K · filed 2014-03-11 |
| 2011-12-31 | $363.00K 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |